Seeing Is Believing
Strongbridge Biopharma plc's activity chart (see below) currently has 17 price targets and 18 ratings on display.
Most recent stock forecast was given by FRANCOIS BRISEBOIS from OPPENHEIMER on 25-May-2021. First documented stock forecast 07-Dec-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Dec-2018
$3.25
$1.25 (62.50%)
5 years 4 months 1 days ago
(25-May-2021)
0/3 (0%)
$0.53 (19.49%)
Buy Since 07-Dec-2015
$3.25
$1.25 (62.50%)
5 years 4 months 2 days ago
(24-May-2021)
0/2 (0%)
$0.55 (20.37%)
Buy Since 11-Aug-2017
$8
$6 (300.00%)
$7
5 years 10 months 14 days ago
(12-Nov-2020)
0/5 (0%)
$5.39 (206.51%)
Buy Since 25-Apr-2016
$15
5 years 10 months 27 days ago
(30-Oct-2020)
0/1 (0%)
$9.54 (174.73%)
Buy Since 24-Sep-2019
$8
$6 (300.00%)
7 years 2 days ago
(24-Sep-2019)
0/1 (0%)
$5.43 (211.28%)
Which analyst most recently updated their price target on SBBP (Strongbridge Biopharma plc)?
Which analyst has the most public recommendations on SBBP (Strongbridge Biopharma plc)?
Which analyst is the currently most bullish on SBBP (Strongbridge Biopharma plc)?
Which analyst is the currently most reserved on SBBP (Strongbridge Biopharma plc)?